Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

J&JPRD and Proteros in agreement for structure-based lead generation
November 2010
SHARING OPTIONS:

MARTINSRIED, GermanyŚJohnson & Johnson Pharmaceutical Research & Development LLC (J&JPRD) and Proteros biostructures GmbH recently signed an agreement under which Proteros will perform research to discover small-molecule lead compounds against a specific target for delivery to J&JPRD.
 
Under the agreement, Proteros will deploy its lead discovery approach that interlinks structural biology, screening of a tailor-made in-house compound and fragment library, compound profiling, and medicinal chemistry activities aimed at rapid fragment evolution and lead finding.
 
Financial terms of the agreement were not disclosed.  

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.